Statements, other than historical facts, contained in this Quarterly Report on Form 10-Q, including statements of potential acquisitions and our strategies, plans and objectives, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Although we believe that our forward-looking statements are based on reasonable assumptions, we caution that such statements are subject to a wide range of risks, trends and uncertainties that could cause actual results to differ materially from those projected. Among those risks, trends and uncertainties are important factors that could cause actual results to differ materially from the forward looking statements, including, but not limited to; the time management devotes to identifying a target business; management's ability to consummate a business combination; the financial condition of the target company with which we may enter a business combination; the effect of existing and future laws; governmental regulations; political and economic conditions; and conditions in the capital markets. We undertake no duty to update or revise these forward-looking statements.

When used in this Form 10-Q, the words, "expect," "anticipate," "intend," "plan," "believe," "seek," "estimate" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Because these forward-looking statements involve risks and uncertainties, actual results could differ materially from those expressed or implied by these forward-looking statements for a number of important reasons.





Overview


Prior to the acquisition of CBD Brand Partners, the Company was engaged in the identification of suitable opportunities for a business transaction.

On April 12, 2021, the Company completed the acquisition of CBDBP.






         25

  Table of Contents



The Company is an integrated, seed-to-shelf operation which includes the growing, processing, extraction, and manufacture of cannabidiol ("CBD") products. The Company believes that it is positioned to become an industry leader. It maintains the highest standards, is GMP certified and tracks its products utilizing a proprietary system to maintain chain of custody and to ensure the safety and efficacy of its products. The Company continues to make improvements in order to build on and maintain its competitive advantage.

On April 19, 2021, the Company filed what is commonly called a Super 8K that provides the information that would be filed via a Form 10 registration. Upon making that filing with the SEC disclosing the cessation of the Company's status as a shell company. Due to the Company's former shell status, certain exemptions are not available for different mandated periods of time. The Company is prohibited from using Form S-8 until sixty calendar days after the date it filed its Super 8K. Additionally, Rule 144 under the Act provides an exemption from the registration requirements of the Securities Act and allows the holders of restricted securities to sell their securities utilizing one of the provisions of this Rule. However, Rule 144 specifically precludes reliance by holders of securities of shell companies such as ours has been historically classified or any issuer that has been at any time previously a shell company, except if the following conditions are met:





    ·   The issuer of the securities that was formerly a shell company has ceased
        to be a shell company;

    ·   The issuer of the securities is subject to the reporting requirements of
        Section 13 or 15(d) of the Exchange Act;

    ·   The issuer of the securities has filed all Exchange Act reports and
        material required to be filed, as applicable, during the preceding 12
        months (or such shorter period that the issuer was required to file such
        reports and materials), other than current reports on Form 8-K; and

    ·   At least one year has elapsed from the time that the issuer filed current
        comprehensive disclosure with the SEC reflecting its status as an entity
        that is not a shell company.



The Company has met all of the conditions above with the exception of the final one which will not be met until one year has elapsed.

Our common stock is a "penny stock," as defined in Rule 3a51-1 promulgated by the SEC under the Exchange Act. The penny stock rules require a broker-dealer, among other things, prior to a transaction in penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the nature and level of risks in the penny stock market. A broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly account statements showing the market value of each penny stock held in the customer's account. In addition, the penny stock rules require that the broker-dealer, not otherwise exempt from such rules, must make a special written determination that the penny stock is suitable for the purchaser and receive the purchaser's written agreement to the transaction. These disclosure rules have the effect of reducing the level of trading activity in the secondary market for a stock that becomes subject to the penny stock rules. So long as our common stock is subject to the penny stock rules, it may be more difficult for us and you to sell your common stock.






         26

  Table of Contents




Emerging Growth Company

We are an "emerging growth company" as defined in Section 2(a)(19) of the Securities Act of 1933, as amended (the "Securities Act"), as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"). As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not "emerging growth companies" including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the "Sarbanes-Oxley Act"), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We intend to take advantage of all of these exemptions.

In addition, Section 107 of the JOBS Act also provides that an "emerging growth company" can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards, and delay compliance with new or revised accounting standards until those standards are applicable to private companies. We have elected to take advantage of the benefits of this extended transition period.

We could be an "emerging growth company" until the last day of the first fiscal year following the fifth anniversary of our first common equity offering, although circumstances could cause us to lose that status earlier if our annual revenues exceed $1.0 billion, if we issue more than $1.0 billion in non-convertible debt in any three-year period or if we become a "large-accelerated filer" as defined in Rule 12b-2 under the Exchange Act.

Smaller Reporting Company

We also qualify as a "smaller reporting company" under Rule 12b-2 of the Exchange Act, which is defined as a company with a public equity float of less than $250 million or less than $100 million in annual revenues and no public float or a public float of less than $700 million. To the extent that we remain a smaller reporting company, we will have reduced disclosure requirements for our public filings, including: (1) less extensive narrative disclosure than required of other reporting companies, particularly in the description of executive compensation and (2) the requirement to provide only two years of audited financial statements, instead of three years. In addition, until such time as the public float of our common stock exceeds $75 million, we will be a non-accelerated filer and will not be required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes Oxley Act.





Results of Operations


Results of Operations during the three months ended March 31, 2022, as compared to the three months ended March 31, 2021

During the three months ended March 31, 2022, and 2021, Our net revenue for the three months ended March 31, 2022, was $1,494,390 compared to $2,162,032, for the same period in 2021.

Our cost of goods sold for the three months ended March 31, 2022, was $854,283, compared to $1,126,244 for the same period in 2021.

Our general and administrative expense for the three months ended March 31, 2022, was $356,977, compared to $210,166 for the same period in 2021. This increase was mainly due to the acquisition.

Our salary expense for the three months ended March 31, 2022, was $601,430 compared to $368,660 for the same period in 2021. This increase was mainly due to the acquisition.

Our rent expense for the three months ended March 31, 2022, was $101,883, compared to $129,735 for the same period in 2021.

Our utilities expense for the three months ended March 31, 2022, was $27,123, compared to $33,453 the same period in 2021.

Our professional fees expense for the three months ended March 31, 2022, was $64,164, compared to $26,120 for the same period in 2021. This increase was mainly due to the acquisition of CBDBP.






         27

  Table of Contents



Our consulting expense for the three months ended March 31, 2022, was $237,948 compared to $217,352 for the same period in 2021. This increase was mainly due to acquisition and related expenses.

Our depreciation expense for the three months ended March 31, 2022, was $95,174, compared to $96,106 for the same period in 2021. This increase was mainly due to the issuance of our employee stock options.

Our share-based expense for the three months ended March 31, 2022, was $95,174, compared to $0 for the same period in 2021. This increase was mainly due to the issuance of our employee stock options.

Our shares issued for inducement expense for the three months ended March 31, 2022, was $82,100, compared to $0 for the same period in 2021. This increase was mainly due to the issuance of commitment shares.

Our financing fees expense for the three months ended March 31, 2022, was $47,371, compared to $1,492,127 for the same period in 2021. This decrease was mainly due to the issuance of commitment shares and common stock warrants in 2021.

Our Interest expense for the three months ended March 31, 2022, was $186,203, compared to $30,544 for the same period in 2021. This increase was mainly due to the acquisition of CBDBP.

Our net loss for the three months ended March 31, 2022, was $1,255,733 compared to $1,568,475 for the same period in 2021. This increase was mainly due to the factors listed above.

Liquidity and Capital Resources

As of March 31, 2022, the Company current assets of $1,670,460 and total assets of $4,077,501 As of December 31, 2021, the Company current assets of $1,513,667 and total assets of $4,007,465.

As of March 31, 2022, the Company current liabilities of $6,162,547 and total Liabilities of $6,412,070 As of December 31, 2021, the Company current liabilities of $5,327,491 and total liabilities of $5,577,014

The Company has funded its operations from contributions made by management and outside investors. The Company has a funding agreement with a third-party investor as discussed above; however, the investor's obligation to provide additional capital is solely at the third-party's discretion.

At present, the Company has business operations which management believes are sufficient to allow the Company to maintain operations. The Company's cash requirements to continue to grow the Company may exceed cash flow from operations requiring the Company to seek additional capital sources. If we require additional financing, we cannot predict whether equity or debt financing will become available at terms acceptable to us, if at all. The Company depends upon services provided by management to fulfill its filing obligations under the Exchange Act.





The following table summarizes our cash flows for the three months ended March
31, 2022 and 2021.



                                                         2022           2021

Net cash provided (used) from operating activities $ (325,197 ) $ 83,320


 Net cash used in investing activities                   (24,230 )     (43,528 )
 Net cash provided by financing activities               326,820       778,109
 Net Increase (Decrease) In Cash                      $  (22,607 )   $ 817,901




Going Concern


Our modest revenues, continuing operating losses and lack of operating capital create substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on growing its revenues and minimizing our expenses, its ability to obtain capital from our affiliates to fund our operations, generate cash from the sale of its securities and attain future profitable operations. Management's plans include selling its equity securities and obtaining debt financing to fund its capital requirements and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.






         28

  Table of Contents



Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.





Contractual Obligations



As a "smaller reporting company," as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.

© Edgar Online, source Glimpses